- Home
- FTAIN vs VCEL Comparison
FTAIN vs VCEL Comparison
Compare FTAIN & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTAIN
- VCEL
- Stock Information
- Founded
- FTAIN N/A
- VCEL 1989
- Country
- FTAIN United States
- VCEL United States
- Employees
- FTAIN 580
- VCEL N/A
- Industry
- FTAIN Misc Corporate Leasing Services
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FTAIN Industrials
- VCEL Health Care
- Exchange
- FTAIN Nasdaq
- VCEL Nasdaq
- Market Cap
- FTAIN N/A
- VCEL 2.1B
- IPO Year
- FTAIN N/A
- VCEL 1997
- Fundamental
- Price
- FTAIN $25.40
- VCEL $40.15
- Analyst Decision
- FTAIN
- VCEL Strong Buy
- Analyst Count
- FTAIN 0
- VCEL 8
- Target Price
- FTAIN N/A
- VCEL $62.00
- AVG Volume (30 Days)
- FTAIN N/A
- VCEL 423.4K
- Earning Date
- FTAIN N/A
- VCEL 07-31-2025
- Dividend Yield
- FTAIN N/A
- VCEL N/A
- EPS Growth
- FTAIN N/A
- VCEL 521.85
- EPS
- FTAIN N/A
- VCEL 0.05
- Revenue
- FTAIN N/A
- VCEL $238,541,000.00
- Revenue This Year
- FTAIN N/A
- VCEL $23.03
- Revenue Next Year
- FTAIN N/A
- VCEL $24.52
- P/E Ratio
- FTAIN N/A
- VCEL $803.09
- Revenue Growth
- FTAIN N/A
- VCEL 14.80
- 52 Week Low
- FTAIN N/A
- VCEL $37.39
- 52 Week High
- FTAIN N/A
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- FTAIN 61.36
- VCEL 44.33
- Support Level
- FTAIN $25.25
- VCEL $40.53
- Resistance Level
- FTAIN $25.48
- VCEL $43.57
- Average True Range (ATR)
- FTAIN 0.20
- VCEL 1.62
- MACD
- FTAIN 0.04
- VCEL -0.16
- Stochastic Oscillator
- FTAIN 88.24
- VCEL 28.65
About FTAIN FTAI Aviation Ltd. 8.25% Fixed - Rate Reset Series C Cumulative Perpetual Redeemable Preferred Shares
FTAI Aviation Ltd is a aerospace company .It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate stable cash flows with the potential for earnings growth and asset appreciation.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.